Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone open-label extension in pediatric bipolar I disorder
NCT00265330Phase 3Completed
- Sponsor
- Viatris
- Start
- Mar 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ziprasidone in bipolar I disorder, sponsored by Viatris. Started Mar 2006; status: completed.
02
Drugs
ziprasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00265330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265330.